Page last updated: 2024-09-03

ro 8-0576 and levodopa methyl ester

ro 8-0576 has been researched along with levodopa methyl ester in 3 studies

Compound Research Comparison

Studies
(ro 8-0576)
Trials
(ro 8-0576)
Recent Studies (post-2010)
(ro 8-0576)
Studies
(levodopa methyl ester)
Trials
(levodopa methyl ester)
Recent Studies (post-2010) (levodopa methyl ester)
214636790819

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnoli, A; Carta, A; Marsden, CD; Quinn, NP; Ruggieri, S; Steiger, MJ; Stocchi, F1
Itoh, S; Oo, C1
Cai, Y; Liu, Z; Ren, T; Wu, N; Yang, X; Yuan, W1

Other Studies

3 other study(ies) available for ro 8-0576 and levodopa methyl ester

ArticleYear
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
    Clinical neuropharmacology, 1991, Volume: 14, Issue:3

    Topics: Administration, Oral; Aged; Benserazide; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease

1991
A feasibility study of differential delivery of levodopa ester and benserazide using site-specific intestinal loops in rats.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:1

    Topics: Animals; Antiparkinson Agents; Benserazide; Delayed-Action Preparations; Drug Combinations; Feasibility Studies; Infusion Pumps; Intestinal Absorption; Intestinal Mucosa; Intestines; Levodopa; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution

2010
Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats.
    Neuroscience letters, 2011, Sep-15, Volume: 502, Issue:2

    Topics: Animals; Antiparkinson Agents; Benserazide; Delayed-Action Preparations; Disease Models, Animal; Dopamine Agents; Drug Combinations; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Reaction Time

2011